NYSEMKT: RGNT
Regentis Biomaterials Ltd Stock Ownership - Who owns Regentis Biomaterials?

Insider buying vs selling

Have Regentis Biomaterials Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when RGNT insiders and whales buy or sell their stock.

RGNT Shareholders

What type of owners hold Regentis Biomaterials Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jeff Dykan2.52%130,465$194.39kInsider
Pini Benelazar2.48%128,666$191.71kInsider
Rosali0.01%702$1.05kInstitution
Rosalind Advisors Inc0.01%701$1.04kInstitution
Warberg Asset Management LLC0.00%87$129.63Institution
Warber0.00%87$129.63Institution
Jane Street Group LLC0.00%43$64.07Institution
Janstr0.00%43$64.07Institution
Renaissance Technologies LLC0.00%13$19.37Institution
Rentec0.00%13$19.37Institution

1 of 2

RGNT vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RGNT0.02%5.00%
LUCY0.01%74.36%Net SellingNet Selling
CUPR0.00%100.00%
NXGL0.03%99.97%Net Selling
FEMY0.02%24.03%Net BuyingNet Buying

Regentis Biomaterials Stock Ownership FAQ

Who owns Regentis Biomaterials?

Regentis Biomaterials (NYSEMKT: RGNT) is owned by 0.02% institutional shareholders, 5.00% Regentis Biomaterials insiders, and 94.98% retail investors. Jeff Dykan is the largest individual Regentis Biomaterials shareholder, owning 130,465.00 shares representing 2.52% of the company. Jeff Dykan's Regentis Biomaterials shares are currently valued at $182.65k.

If you're new to stock investing, here's how to buy Regentis Biomaterials stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.